Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Primary or secondary daytime urinary incontinence, persistent over at least 6 months of medical treatment.~* Abnormal urodynamic testing~* Normal conus on magnetic resonance imaging of the spine~* Dysfunctional Voiding Symptom Scale score greater than 6 for girls or greater than 9 for boys~Exclusion Criteria:~* Bladder outlet obstruction~* Bladder atony~* Congenital anorectal malformation~* Additional diagnoses independently associated with neurogenic bladder dysfunction~* Encephalopathy precluding reasonable expectation of attainment of continence~* Inability to comply with medical management~* Unwillingness to comply with initial or follow up urodynamic testing

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Neurogenic incontinence (Type: None): The target population of this study is children with primary or secondary daytime urinary incontinence, who have failed to improve adequately despite compliance with at least 6 months of standard medical therapy. These children will have abnormal urodynamics, a normal bladder ultrasound and an MR imaging showing that the conus of the spinal cord is at a normal position and that there is no other significant dysraphic lesion present.

Based on this trial design, predict the completion outcome and termination type (if applicable).